Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2003
03/13/2003WO2003020765A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020761A1 Modified human growth hormone
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020756A2 Hybrid and tandem expression of neisserial proteins
03/13/2003WO2003020755A1 Mutated env gene, mutated env glycoprotein and the use thereof
03/13/2003WO2003020750A2 Antigen mimotopes and vaccine against cancers
03/13/2003WO2003020747A1 Modified peptides and their use for the treatment of autoimmune diseases
03/13/2003WO2003020746A1 Modified transferrin fusion proteins
03/13/2003WO2003020371A2 Potentiator composition comprising a terpene for enhancing a therapeutical effect of antitumoral agents in the treatment of cancer
03/13/2003WO2003020322A1 Vector used to induce an immune response
03/13/2003WO2003020308A1 Chicken anemia virus vaccine from cell line
03/13/2003WO2003020306A1 Desensitizers
03/13/2003WO2003020290A1 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
03/13/2003WO2003020287A2 Methods for the treatment of chronic pain anc compositions therefor
03/13/2003WO2003020215A2 Methods of treating mycocardial event related coditions with thymosin beta 4
03/13/2003WO2003020212A2 Treatment for central nervous system disorders
03/13/2003WO2003020172A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
03/13/2003WO2003020040A1 Oral vaccines
03/13/2003WO2003020039A1 Immune tolerance to predetermined antigens
03/13/2003WO2003000847A3 Membrane associated progesterone receptor
03/13/2003WO2002099038A3 Adsls as modifiers of the p53 pathway and methods of use
03/13/2003WO2002089796A3 Methods for selective immunomodulation using pimecrolimus
03/13/2003WO2002085932A3 Constructs and methods for expression of recombinant hcv envelope proteins
03/13/2003WO2002081653A3 An animal model for enteric pathogens
03/13/2003WO2002079237A3 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
03/13/2003WO2002078742A3 Methods and compositions for treatment of immune dysfunction disorders
03/13/2003WO2002078715A8 Method for induction of an antigen specific anti-inflammatory response
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002076548A3 Methods and apparatus for treating diseased tissue
03/13/2003WO2002075275A3 Polyclonal populations of bispecific molecules and methods of production and uses thereof
03/13/2003WO2002068654A3 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
03/13/2003WO2002067846A3 A vaccine composition and method of using the same
03/13/2003WO2002067760A3 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/13/2003WO2002064741A3 Compositions and methods relating to breast specific genes and proteins
03/13/2003WO2002063012A3 Ragweed allergens
03/13/2003WO2002057784A3 Chlamydia heat shock protein
03/13/2003WO2002055104A3 Acne vaccine
03/13/2003WO2002053180A3 Immunizing compositions and methods of use
03/13/2003WO2002048675A3 Improved compositions and methods for producing antibodies to low molecular weight analytes
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002044364A3 Polypeptides involved in immune response
03/13/2003WO2002042456A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002034773A3 Streptococcal genes
03/13/2003WO2002034288A3 Vaccine for treating allergy
03/13/2003WO2002032936A3 E. histolytica-specific antibodies and clinical uses thereof
03/13/2003WO2002030986A3 HUMANIZED ANTI-LT-β-R ANTIBODIES
03/13/2003WO2002026984A3 Potassium channel interactors and uses therefor
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2002026801A3 Secreted proteins and their uses
03/13/2003WO2002020571A3 Attenuated hiv strains and use thereof
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002016416A3 Diagnosis and treatment of cardiovascular conditions
03/13/2003WO2002014487A3 Adeno-associated virus-mediated delivery of angiogenic factors
03/13/2003WO2002012272A8 Therapeutic anti-melanoma compounds
03/13/2003WO2002008284A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002006340A3 Tetraspan protein and uses thereof
03/13/2003WO2002004494A3 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof
03/13/2003WO2002002639A3 Human ion channels
03/13/2003WO2002000690A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002000242A8 Human papilloma virus treatment
03/13/2003WO2001096376A3 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003US20030051259 Packaging cells
03/13/2003US20030050468 Synthetic HIV gag genes
03/13/2003US20030050466 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer or autoimmune diaseses
03/13/2003US20030050463 Nucleotide sequences encoding fusion protein for use in generation of vaccines against viral diseases
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050456 Nucleotide sequences coding polypeptide for use in the treatment of brain and psychological disorders
03/13/2003US20030050451 Peptide for use in the diagnosis and treatment of tumors
03/13/2003US20030050447 Polypeptide for use in the generation of vaccine against diphtheria toxin
03/13/2003US20030050439 Polypeptide for use in the treatment of tumors and warts
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050263 Methods and products for treating HIV infection
03/13/2003US20030050262 Inhibition of neurodegeneration
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050244 Controlling the action of cytokines, particularly chemokines, by inhibiting their binding with receptors; used as immunogens for use as metazoan parasite vaccines; antiallergens; veterinary medicine
03/13/2003US20030050239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050235 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
03/13/2003US20030050224 Treatment of glial tumors with glutamate antagonists
03/13/2003US20030049844 Recombinant canine herpesviruses
03/13/2003US20030049843 Gene delivery vectors with cell type specificity for mesenchymal stem cells
03/13/2003US20030049830 Herpes virus complementing cell line
03/13/2003US20030049828 Oncogenic protein for use in the diagnosis and treatment of tumors
03/13/2003US20030049825 Nervous necrosis virus protein
03/13/2003US20030049800 Compositions and methods for producing antibodies to low molecular weight analytes
03/13/2003US20030049797 Hybrid proteins for autoimmune disease
03/13/2003US20030049791 Goodpasture antigen binding protein
03/13/2003US20030049728 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049691 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander
03/13/2003US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus
03/13/2003US20030049684 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049683 Rationally designed antibodies
03/13/2003US20030049651 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer
03/13/2003US20030049648 37 staphylococcus aureus genes and polypeptides
03/13/2003US20030049633 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 ... 1823